DK1523985T3 - Ikke-radioaktivt strontiumholdigt middel til behandling af kræft - Google Patents
Ikke-radioaktivt strontiumholdigt middel til behandling af kræftInfo
- Publication number
- DK1523985T3 DK1523985T3 DK03103850.8T DK03103850T DK1523985T3 DK 1523985 T3 DK1523985 T3 DK 1523985T3 DK 03103850 T DK03103850 T DK 03103850T DK 1523985 T3 DK1523985 T3 DK 1523985T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- treatment
- containing agent
- radioactive strontium
- prophylaxis
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 title abstract 4
- 229910052712 strontium Inorganic materials 0.000 title abstract 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03103850A EP1523985B1 (en) | 2003-10-17 | 2003-10-17 | Non-radioactive strontium agent for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1523985T3 true DK1523985T3 (da) | 2010-05-31 |
Family
ID=34354592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03103850.8T DK1523985T3 (da) | 2003-10-17 | 2003-10-17 | Ikke-radioaktivt strontiumholdigt middel til behandling af kræft |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20070031476A1 (da) |
| EP (1) | EP1523985B1 (da) |
| CN (1) | CN1886143B (da) |
| AT (1) | ATE460168T1 (da) |
| AU (1) | AU2004281559B2 (da) |
| DE (1) | DE60331654D1 (da) |
| DK (1) | DK1523985T3 (da) |
| ES (1) | ES2342461T3 (da) |
| NO (1) | NO20062229L (da) |
| RU (1) | RU2363479C2 (da) |
| WO (1) | WO2005037295A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI122450B (fi) * | 2007-12-28 | 2012-01-31 | Neurofood Ab Oy | Koostumus steriilin inflammaation hoitoon |
| CN103153267B (zh) * | 2010-08-18 | 2015-07-22 | 高露洁-棕榄公司 | 口腔护理产品及其使用和制备方法 |
| FI123756B (fi) * | 2010-09-21 | 2013-10-31 | Neurofood Ab Oy | Parannettu lisäravinne syövän hoitamiseksi tai ennaltaehkäisemiseksi |
| EP2530068A1 (en) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
| WO2013013003A1 (en) * | 2011-07-21 | 2013-01-24 | Emory University | Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation |
| CA2955914C (en) * | 2014-07-21 | 2022-09-06 | Ignacio Canals Almazan | Tungsten (vi) salts for use thereof in the treatment of infertility, for favoring normal reproduction and fertility in a non-diabetic female mammal, as well as for improving the efficacy of assisted reproductive techniques |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB602029A (en) * | 1942-04-17 | 1948-05-19 | Western Condensing Co | Improvements in or relating to process of manufacturing a vitamin concentrate |
| GB602209A (en) * | 1945-06-13 | 1948-05-21 | Norton Co | Hydraulic table reciprocating mechanism |
| EP0366869A3 (en) * | 1988-10-17 | 1991-06-12 | Lycon Ag | Bacteriostatic, bactericidal and antifungal composition and methods of use thereof |
| CN1082845A (zh) | 1992-12-21 | 1994-03-02 | 颜怀玮 | 营养平衡强化型矿泉水及制造方法 |
| CN1053091C (zh) * | 1993-03-13 | 2000-06-07 | 彭建汉 | 天然竹汁保健饮料 |
| CN1113720A (zh) * | 1994-05-24 | 1995-12-27 | 云南智成科技实业公司 | 保健液及其生产方法 |
| US5650316A (en) * | 1994-06-06 | 1997-07-22 | Research Development Foundation | Uses of triplex forming oligonucleotides for the treatment of human diseases |
| EP0737471A3 (fr) * | 1995-04-10 | 2000-12-06 | L'oreal | Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue |
| FR2740341B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
| CN1153053A (zh) * | 1995-12-28 | 1997-07-02 | 汪贵昌 | 一种治疗肿瘤的克癌灵中药 |
| US5916143A (en) * | 1996-04-30 | 1999-06-29 | Apple; Marc G. | Brachytherapy catheter system |
| CA2339473A1 (en) * | 1998-08-04 | 2000-02-17 | John V. Kosbab | Nutrient and therapeutic compositions for the treatment of cancer |
| WO2001015552A1 (en) | 1999-08-30 | 2001-03-08 | Ocean Nutrition Canada Ltd. | A nutritional supplement for lowering serum triglyceride and cholesterol levels |
| WO2001041821A1 (en) * | 1999-12-09 | 2001-06-14 | Biosyntech Canada Inc. | Mineral-polymer hybrid composition |
| US6456680B1 (en) * | 2000-03-29 | 2002-09-24 | Tci Incorporated | Method of strontium-89 radioisotope production |
| NO20014746D0 (no) * | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
| WO2003075957A1 (en) * | 2002-03-04 | 2003-09-18 | Medimmune, Inc. | The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
-
2003
- 2003-10-17 DE DE60331654T patent/DE60331654D1/de not_active Expired - Lifetime
- 2003-10-17 ES ES03103850T patent/ES2342461T3/es not_active Expired - Lifetime
- 2003-10-17 EP EP03103850A patent/EP1523985B1/en not_active Expired - Lifetime
- 2003-10-17 AT AT03103850T patent/ATE460168T1/de not_active IP Right Cessation
- 2003-10-17 DK DK03103850.8T patent/DK1523985T3/da active
-
2004
- 2004-10-15 AU AU2004281559A patent/AU2004281559B2/en not_active Ceased
- 2004-10-15 WO PCT/FI2004/000618 patent/WO2005037295A1/en active Application Filing
- 2004-10-15 US US10/575,752 patent/US20070031476A1/en not_active Abandoned
- 2004-10-15 RU RU2006115785/15A patent/RU2363479C2/ru not_active IP Right Cessation
- 2004-10-15 CN CN2004800350230A patent/CN1886143B/zh not_active Expired - Fee Related
-
2006
- 2006-05-18 NO NO20062229A patent/NO20062229L/no not_active Application Discontinuation
-
2009
- 2009-11-30 US US12/626,980 patent/US8703211B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004281559A1 (en) | 2005-04-28 |
| NO20062229L (no) | 2006-05-18 |
| DE60331654D1 (de) | 2010-04-22 |
| US20070031476A1 (en) | 2007-02-08 |
| EP1523985B1 (en) | 2010-03-10 |
| RU2363479C2 (ru) | 2009-08-10 |
| ATE460168T1 (de) | 2010-03-15 |
| ES2342461T3 (es) | 2010-07-07 |
| WO2005037295A1 (en) | 2005-04-28 |
| CN1886143A (zh) | 2006-12-27 |
| CN1886143B (zh) | 2011-04-06 |
| AU2004281559B2 (en) | 2010-04-01 |
| RU2006115785A (ru) | 2007-11-27 |
| US8703211B2 (en) | 2014-04-22 |
| US20100074968A1 (en) | 2010-03-25 |
| EP1523985A1 (en) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1505990T3 (da) | Fremgangsmåder til behandling af hepatitis | |
| SE0301700D0 (sv) | Novel compounds | |
| RS20060320A (en) | Substituted indazole-o-glucosides | |
| SG130189A1 (en) | Substituted indole-o-glucosides | |
| BR0307058A (pt) | N-óxidos de derivados de n-fenil-2-pirimidina-amina | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| UA86042C2 (en) | Substituted indazole-o-glucosides | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| PL376409A1 (en) | Composition for the treatment of infection by flaviviridae viruses | |
| DK1560812T3 (da) | Aminocyclohexyletherforbindelser og anvendelser deraf | |
| TW200716088A (en) | Formulations and methods for treating amyloidosis | |
| DK1499730T3 (da) | Immunokonjugater til behandling af tumorer | |
| NO20054535L (no) | Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| SE0301650D0 (sv) | Novel compounds | |
| WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
| EP1551388A4 (en) | COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME | |
| NO20062229L (no) | Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er) | |
| SE0300457D0 (sv) | Novel compounds | |
| DK2042182T3 (da) | Farmaceutisk sammensætning, der omfatter arsen, til behandling af malignitet. | |
| BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
| ATE391489T1 (de) | Haarbehandlungszusammensetzungen | |
| MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
| DK1521752T3 (da) | Makrocykliske forbindelser til behandling af cancer | |
| ITRM20030442A0 (it) | Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia. |